Supplementation of amino acids to prevent reperfusion injury after liver surgery and transplantation – Where do we stand today?

scientific article published on October 20, 2010

Supplementation of amino acids to prevent reperfusion injury after liver surgery and transplantation – Where do we stand today? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CLNU.2010.09.006
P8608Fatcat IDrelease_sge3b6aj6zaebazlkyeo7mmsxi
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S0261561410001792?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:S0261561410001792?httpAccept=text/xml
P698PubMed publication ID20965621

P50authorMarkus BüchlerQ89169
P2093author name stringKatrin Hoffmann
Markus W. Büchler
Peter Schemmer
P2860cites workHEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].Q24813738
Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation?Q74359379
Glycine rinse protects against liver injury during transplantationQ74616329
Exogenous L-arginine protects liver microcirculation from ischemia reperfusion injuryQ74649526
The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantationQ74779411
Taurine blunts LPS-induced increases in intracellular calcium and TNF-alpha production by Kupffer cellsQ77584404
Dietary amino acid taurine ameliorates liver injury in chronic hepatitis patientsQ80778551
Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective databaseQ33362747
Glycine: a new anti-inflammatory immunonutrientQ34158641
Hepatic ischemia-reperfusion injuryQ34292863
Reperfusion injury after liver preservation for transplantationQ34424314
L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agentQ35067484
Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubulesQ35582060
PROUD: effects of preoperative long-term immunonutrition in patients listed for liver transplantationQ36059764
Liver transection using vascular stapler: a reviewQ37261379
Dietary glycine blunts liver injury after bile duct ligation in ratsQ37383130
Inflammatory mediators of liver ischemia-reperfusion injuryQ37588750
Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resectionQ40757028
Role of sinusoidal lining cells in hepatic reperfusion injury following cold storage and transplantationQ40883027
Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker, nisoldipine.Q41234637
Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonistsQ41391248
The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonusQ42483083
Arginine-specific proteolytic activity predicts graft survivalQ43552694
Activated Kupffer cells cause a hypermetabolic state after gentle in situ manipulation of liver in ratsQ43607573
N-acetylcysteine attenuates the increase in alpha-glutathione S-transferase and circulating ICAM-1 and VCAM-1 after reperfusion in humans undergoing liver transplantationQ43729208
Influence of N-acetylcysteine on hepatic amino acid metabolism in patients undergoing orthotopic liver transplantationQ43787728
Glycine reduces reperfusion injury in human liver transplantation: our first patientsQ43828684
Reduced reperfusion injury by glycine in a porcine liver transplantation model with non-heart-beating donorsQ44033339
Extended experience with glycine for prevention of reperfusion injury after human liver transplantationQ44148891
Effect of hepatic artery flow on bile secretory function after cold ischemiaQ44326126
The influence of preservation injury on rejection in the hepatic transplant recipientQ44596393
Membrane stabilizing effects of glycine during kidney cold storage and reperfusionQ45703446
Effect of N-acetylcysteine administration on intraoperative plasma levels of interleukin-4 and interleukin-10 in liver transplant recipientsQ46246082
Donor preconditioning with taurine protects kidney grafts from injury after experimental transplantationQ46864449
Gentle in situ liver manipulation during organ harvest decreases survival after rat liver transplantation: role of Kupffer cells.Q50524365
Taurine protects from liver injury after warm ischemia in rats: the role of kupffer cells.Q50693978
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.Q50886303
Effect of total hepatic vascular exclusion during liver resection on hepatic ultrastructure.Q50927959
Stapler hepatectomy is a safe dissection technique: analysis of 300 patients.Q51274339
Sulfhydryl group involvement in the modulation of guanosine 3′,5′-monophosphate metabolism by nitric oxide, norepinephrine, pyruvate and t-butyl hydroperoxide in minced rat lungQ67263851
Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trialQ69892062
Reduction of liver taurine in rats by beta-alanine treatment increases carbon tetrachloride toxicityQ70582012
Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantationQ71075866
The effect of taurine administration on patients with acute hepatitisQ71808368
Inhibition of nonlysosomal calcium-dependent proteolysis by glycine during anoxic injury of rat hepatocytesQ72693603
Glycogenolytic effect of adenosine involves ATP from hepatocytes and eicosanoids from Kupffer cellsQ72764698
Treatment of experimental ischemia/reperfusion injury with S-adenyosylmethionine: evidence that donor pretreatment complements other regimensQ73103713
Gentle in situ liver manipulation during organ harvest increases oxygen consumption in liverQ73506814
IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humansQ73515861
Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flowQ73574828
Taurine attenuates cold ischemia-reoxygenation injury in rat liverQ73928299
Cytoprotection by the osmolytes betaine and taurine in ischemia-reoxygenation injury in the perfused rat liverQ73939869
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectreperfusion injuryQ1413991
P304page(s)143-147
P577publication date2010-10-20
P1433published inClinical NutritionQ15764056
P1476titleSupplementation of amino acids to prevent reperfusion injury after liver surgery and transplantation--where do we stand today?
Supplementation of amino acids to prevent reperfusion injury after liver surgery and transplantation – Where do we stand today?
P478volume30

Reverse relations

cites work (P2860)
Q94452549Benefits of N-acetylcysteine on liver functions in living donor hepatectomy
Q47231338Current evidence for the use of N-acetylcysteine following liver resection.
Q40848408Early markers of reperfusion injury after liver transplantation: association with primary dysfunction
Q40700805Effect of N-acetylcysteine on liver recovery after resection: A randomized clinical trial
Q42225377Effects of a preconditioning oral nutritional supplement on pig livers after warm ischemia
Q48287357Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells
Q37951598Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia-reperfusion injury: current knowledge.
Q48119363HTK-N, a modified HTK solution, decreases preservation injury in a model of microsteatotic rat liver transplantation
Q35060309Improved oxidative status in major abdominal surgery patients after N-acetyl cystein supplementation
Q36313395Liver transplantation: Advances and perioperative care
Q38035172Nutrition support and infections associated with hepatic resection and liver transplantation in patients with chronic liver disease
Q52957824Sulforaphane reduces apoptosis and oncosis along with protecting liver injury-induced ischemic reperfusion by activating the Nrf2/ARE pathway.
Q84077709The role of CD14 and Toll-like receptor 4 of Kupffer cells in hepatic ischemia-reperfusion injury in rats
Q38804933The role of glycine in regulated cell death

Search more.